Skip to main content

Advertisement

SpringerLink
Log in

Prevalence and Determinants of Return to Work as a Patient-Centered Outcome in Survivors of Hematopoietic Cell Transplantation

  • Health Economics (N Khera, Section Editor)
  • Published:
Current Hematologic Malignancy Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

Employment is an important indicator of health and functional recovery for hematopoietic cell transplantation (HCT) survivors and has significant social and economic impacts. Cancer survivors treated with conventional non-HCT therapy are known to be at a higher risk of unemployment or not returning to work after completion of therapy compared with the control population. However, the literature on return-to-work challenges among HCT survivors remains limited.

Recent Findings

Here we summarize the evidence on prevalence and determinants of return-to-work challenges among HCT survivors using previously published literature. Findings from previously published research show that return to work or unemployment is a major concern among HCT survivors, especially for allogeneic HCT recipients, and prior studies have identified several modifiable risk factors associated with it. Survivors’ post-HCT employment status is significantly associated with quality of life, impacting physical, emotional, social, and financial aspects of their lives. We also highlight the gaps in current knowledge such as limited information on employment outcomes of childhood, adolescent, and young adult HCT survivors; work-related challenges among employed HCT survivors; consequences of work-related challenges; and interventions to improve return to work among HCT survivors.

Summary

Findings highlighted in this review make a strong case of a multidisciplinary return-to-work support for HCT survivors to properly address their needs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Phelan R, Chen M, Bupp C, et al. Updated trends in hematopoietic cell transplantation in the United States with an additional focus on adolescent and young adult transplantation activity and outcomes. Transplant Cell Ther. 2022;https://doi.org/10.1016/j.jtct.2022.04.012

  2. Majhail NS, Tao L, Bredeson C, et al. Prevalence of hematopoietic cell transplant survivors in the United States. Biol Blood Marrow Transplant. 2013;19(10):1498–501.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Kaiser Family Foundation: health insurance coverage of the total population. Accessed April 5, 2022. https://www.kff.org/other/state-indicator/total-population/?currentTimeframe=0&sortModel=%7B%22colId%22:%22Location%22,%22sort%22:%22asc%22%7D

  4. De Boer AGEM, Taskila T, Ojajärvi A, Van Dijk FJH, Verbeek JHAM. Cancer survivors and unemployment: a meta-analysis and meta-regression. JAMA. 2009;301(7):753–62.

    Article  PubMed  Google Scholar 

  5. van Muijen P, Weevers NL, Snels IA, et al. Predictors of return to work and employment in cancer survivors: a systematic review. Eur J Cancer Care (Engl). 2013;22(2):144–60. https://doi.org/10.1111/ecc.12033.

    Article  PubMed  Google Scholar 

  6. Devine KA, Christen S, Mulder RL, et al. Recommendations for the surveillance of education and employment outcomes in survivors of childhood, adolescent, and young adult cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Cancer. 2022. https://doi.org/10.1002/cncr.34215.Evidence-based clinical practice guidelines to positively influence educational and employment outcomes among childhood cancer survivors.

  7. Armenian SH, Sun CL, Kawashima T, et al. Long-term health-related outcomes in survivors of childhood cancer treated with HSCT versus conventional therapy: a report from the Bone Marrow Transplant Survivor Study (BMTSS) and Childhood Cancer Survivor Study (CCSS). Blood. 2011;118(5):1413–20. https://doi.org/10.1182/blood-2011-01-331835.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Chow EJ, Cushing-Haugen KL, Cheng GS, et al. Morbidity and mortality differences between hematopoietic cell transplantation survivors and other cancer survivors. J Clin Oncol. 2017;35(3):306–13. https://doi.org/10.1200/JCO.2016.68.8457.

    Article  PubMed  Google Scholar 

  9. Kirchhoff AC, Leisenring W, Syrjala KL. Prospective predictors of return to work in the 5 years after hematopoietic cell transplantation. J Cancer Surviv. 2010;4(1):33–44.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Wong FL, Francisco L, Togawa K, et al. Long-term recovery after hematopoietic cell transplantation: predictors of quality-of-life concerns. Blood. 2010;115(12):2508–19. https://doi.org/10.1182/blood-2009-06-225631.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Morrison EJ, Ehlers SL, Bronars CA, et al. Employment status as an indicator of recovery and function one year after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2016;22(9):1690–5.

    Article  PubMed  Google Scholar 

  12. Andrykowski MA, Bishop MM, Hahn EA, et al. Long-term health-related quality of life, growth, and spiritual well-being after hematopoietic stem-cell transplantation. J Clin Oncol. 2005;23(3):599–608. https://doi.org/10.1200/JCO.2005.03.189.

    Article  PubMed  Google Scholar 

  13. Gruber U, Fegg M, Buchmann M, Kolb HJ, Hiddemann W. The long-term psychosocial effects of haematopoetic stem cell transplantation. Eur J Cancer Care (Engl). 2003;12(3):249–56.

    CAS  PubMed  Google Scholar 

  14. Hjermstad MJ, Knobel H, Brinch L, et al. A prospective study of health-related quality of life, fatigue, anxiety and depression 3–5 years after stem cell transplantation. Bone Marrow Transplant. 2004;34(3):257–66. https://doi.org/10.1038/sj.bmt.1704561.

    Article  CAS  PubMed  Google Scholar 

  15. Wingard JR, Curbow B, Baker F, Piantadosi S. Health, functional status, and employment of adult survivors of bone marrow transplantation. Ann Intern Med. 1991;114(2):113–8. https://doi.org/10.7326/0003-4819-114-2-113.

    Article  CAS  PubMed  Google Scholar 

  16. Khera N, Chang Y-h, Hashmi S, et al. Financial burden in recipients of allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2014;20(9):1375–1381. A cross-sectional survey study of hematopoietic cell transplant survivors describing the prevalence and predictors of self-reported financial hardship after transplant.

  17. Gifford G, Gilroy N, Dyer G, et al. The experience of survival following allogeneic haematopoietic stem cell transplantation in New South Wales, Australia. Bone Marrow Transplant. 2016;51(10):1361–8. https://doi.org/10.1038/bmt.2016.135.

    Article  CAS  PubMed  Google Scholar 

  18. Brice L, McErlean G, Donovan C, et al. Fear of cancer recurrence following allogeneic haematopoietic stem cell transplantation (HSCT) for haematological malignancy: a cross-sectional study. Eur J Oncol Nurs. 2020;49:101845. https://doi.org/10.1016/j.ejon.2020.101845.

    Article  PubMed  Google Scholar 

  19. Kurosawa S, Yamaguchi T, Mori A, et al. Resignation and return to work in patients receiving allogeneic hematopoietic cell transplantation close up. J Cancer Surviv. 2021;https://doi.org/10.1007/s11764-021-01092-w

  20. Syrjala KL, Langer SL, Abrams JR, Storer BE, Martin PJ. Late effects of hematopoietic cell transplantation among 10-year adult survivors compared with case-matched controls. J Clin Oncol. 2005;23(27):6596–606. https://doi.org/10.1200/JCO.2005.12.674.

    Article  PubMed  Google Scholar 

  21. Duell T, Van Lint MT, Ljungman P, et al. Health and functional status of long-term survivors of bone marrow transplantation. Ann Intern Med. 1997;126(3):184–92.

    Article  CAS  PubMed  Google Scholar 

  22. Winterling J, Johansson E, Wennman-Larsen A, Petersson LM, Ljungman P, Alexanderson K. Occupational status among adult survivors following allo-SCT. Bone Marrow Transplant. 2014;49(6):836–42.

    Article  CAS  PubMed  Google Scholar 

  23. Hernaes KH, Smeland KB, Fagerli UM, Kiserud CE. Post-treatment work patterns amongst survivors of lymphoma treated with high-dose chemotherapy with autologous stem-cell transplantation. BMC Cancer. 2021;21(1):143. https://doi.org/10.1186/s12885-021-07836-2.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Kiserud CE, Fagerli UM, Smeland KB, et al. Pattern of employment and associated factors in long-term lymphoma survivors 10 years after high-dose chemotherapy with autologous stem cell transplantation. Acta Oncol. 2016;55(5):547–53. https://doi.org/10.3109/0284186X.2015.1125015.

    Article  CAS  PubMed  Google Scholar 

  25. Socie G, Mary JY, Esperou H, et al. Health and functional status of adult recipients 1 year after allogeneic haematopoietic stem cell transplantation. Br J Haematol. 2001;113(1):194–201. https://doi.org/10.1046/j.1365-2141.2001.02678.x.

    Article  CAS  PubMed  Google Scholar 

  26. Syrjala KL, Langer SL, Abrams JR, et al. Recovery and long-term function after hematopoietic cell transplantation for leukemia or lymphoma. JAMA. 2004;291(19):2335–43.

    Article  CAS  PubMed  Google Scholar 

  27. Armstrong GT, Sklar CA, Hudson MM, Robison LL. Long-term health status among survivors of childhood cancer: does sex matter? J Clin Oncol. 2007;25(28):4477–89. https://doi.org/10.1200/JCO.2007.11.2003.

    Article  PubMed  Google Scholar 

  28. Hensel M, Egerer G, Schneeweiss A, Goldschmidt H, Ho AD. Quality of life and rehabilitation in social and professional life after autologous stem cell transplantation. Ann Oncol. 2002;13(2):209–17. https://doi.org/10.1093/annonc/mdf031.

    Article  CAS  PubMed  Google Scholar 

  29. Tichelli A, Gerull S, Holbro A, et al. Inability to work and need for disability pension among long-term survivors of hematopoietic stem cell transplantation. Bone Marrow Transplant. 2017;52(10):1436–42. https://doi.org/10.1038/bmt.2017.115.

    Article  CAS  PubMed  Google Scholar 

  30. Lee SJ, Logan B, Westervelt P, et al. Comparison of patient-reported outcomes in 5-year survivors who received bone marrow vs peripheral blood unrelated donor transplantation: long-term follow-up of a randomized clinical trial. JAMA Oncol. 2016;2(12):1583–9. https://doi.org/10.1001/jamaoncol.2016.2520.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Salit RB, Lee SJ, Syrjala KL. Facilitators of successful return to work in 1–5 year post-HCT survivors. presented at: Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR. 2021.

  32. Bieri S, Roosnek E, Helg C, et al. Quality of life and social integration after allogeneic hematopoietic SCT. Bone Marrow Transplant. 2008;42(12):819–27. https://doi.org/10.1038/bmt.2008.253.

    Article  CAS  PubMed  Google Scholar 

  33. Xie W, Zhang X, Wang J, et al. Evaluation of quality of life and its influencing factors after transplantation of leukemia patients based on SF-36 score: a cohort study. Qual Life Res. 2020;29(7):1809–16. https://doi.org/10.1007/s11136-020-02444-2.

    Article  PubMed  Google Scholar 

  34. Sundberg KK, Wettergren L, Frisk P, Arvidson J. Self-reported quality of life in long-term survivors of childhood lymphoblastic malignancy treated with hematopoietic stem cell transplantation versus conventional therapy. Pediatr Blood Cancer. 2013;60(8):1382–7. https://doi.org/10.1002/pbc.24519.

    Article  PubMed  Google Scholar 

  35. Kurosawa S, Yamaguchi T, Oshima K, et al. Employment status was highly associated with quality of life after allogeneic hematopoietic cell transplantation, and the association may differ according to patient age and graft-versus-host disease status: analysis of a nationwide QOL survey. Bone Marrow Transplant. 2019;54(4):611–5. https://doi.org/10.1038/s41409-018-0343-x.

    Article  PubMed  Google Scholar 

  36. Harder H, Cornelissen JJ, Van Gool AR, Duivenvoorden HJ, Eijkenboom WMH, van den Bent MJ. Cognitive functioning and quality of life in long-term adult survivors of bone marrow transplantation. Cancer. 2002;95(1):183–92.

    Article  PubMed  Google Scholar 

  37. Liang J, Lee SJ, Storer BE, et al. Rates and risk factors for post-traumatic stress disorder symptomatology among adult hematopoietic cell transplant recipients and their informal caregivers. Biol Blood Marrow Transplant. 2019;25(1):145–50. https://doi.org/10.1016/j.bbmt.2018.08.002.

    Article  PubMed  Google Scholar 

  38. Löf CM, Winiarski J, Ljungman P, Forinder U. The socioeconomic and psychosocial circumstances of adult long-term survivors of hematopoietic stem cell transplantation in childhood. Pediatr Transplant. 2011;15(7):691–8.

    Article  PubMed  Google Scholar 

  39. Sanders JE, Hoffmeister PA, Storer BE, Appelbaum FR, Storb RF, Syrjala KL. The quality of life of adult survivors of childhood hematopoietic cell transplant. Bone Marrow Transplant. 2010;45(4):746–54.

    Article  CAS  PubMed  Google Scholar 

  40. Helder DI, Bakker B, De Heer P, et al. Quality of life in adults following bone marrow transplantation during childhood. Bone Marrow Transplant. 2004;33(3):329–36.

    Article  CAS  PubMed  Google Scholar 

  41. Eapen M, Ramsay NK, Mertens AC, Robison LL, DeFor T, Davies SM. Late outcomes after bone marrow transplant for aplastic anaemia. Br J Haematol. 2000;111(3):754–60.

    CAS  PubMed  Google Scholar 

  42. Freycon F, Trombert-Paviot B, Casagranda L, et al. Academic difficulties and occupational outcomes of adult survivors of childhood leukemia who have undergone allogeneic hematopoietic stem cell transplantation and fractionated total body irradiation conditioning. Pediatr Hematol Oncol. 2014;31(3):225–36. https://doi.org/10.3109/08880018.2013.829541.

    Article  PubMed  Google Scholar 

  43. La Nasa G, Caocci G, Efficace F, et al. Long-term health-related quality of life evaluated more than 20 years after hematopoietic stem cell transplantation for thalassemia. Blood. 2013;122(13):2262–70. https://doi.org/10.1182/blood-2013-05-502658.

    Article  CAS  PubMed  Google Scholar 

  44. Bhatt NS, Brazauskas R, Salit RB, et al. Return to work among young adult survivors of allogeneic hematopoietic cell transplantation in the United States. Transplant Cell Ther. 2021;27(8):679 e1–679 e8. https://doi.org/10.1016/j.jtct.2021.04.013. A multi-center study showing the prevalence and predictors of return to work among the vulnerable but understudied population of young adult hematopoietic cell transplant survivors.

  45. Uderzo C, Corti P, Pappalettera M, et al. Life satisfaction in young adults 10 or more years after hematopoietic stem cell transplantation for childhood malignant and nonmalignant diseases does not show significant impairment compared with healthy controls: a case-matched study. Biol Blood Marrow Transplant. 2012;18(11):1759–64. https://doi.org/10.1016/j.bbmt.2012.06.015.

    Article  PubMed  Google Scholar 

  46. Bhatt NS, Brazauskas R, Tecca HR, et al. Post-transplantation employment status of adult survivors of childhood allogeneic hematopoietic cell transplant: a report from the Center for International Blood and Marrow Transplant Research (CIBMTR). Cancer. 2018. https://doi.org/10.1002/cncr.31781.

  47. Kirchhoff AC, Nipp R, Warner EL, et al. “Job Lock” among long-term survivors of childhood cancer: a report from the childhood cancer survivor study. JAMA oncology. 2017;

  48. Crom DB, Ness KK, Martinez LR, et al. Workplace experiences and turnover intention among adult survivors of childhood cancer. J Cancer Surviv. 2018;12(4):469–78. https://doi.org/10.1007/s11764-018-0686-8.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Moskowitz MC, Todd BL, Chen R, Feuerstein M. Function and friction at work: a multidimensional analysis of work outcomes in cancer survivors. J Cancer Surviv. 2014;8(2):173–82. https://doi.org/10.1007/s11764-013-0340-4.

    Article  PubMed  Google Scholar 

  50. Hamilton JG, Wu LM, Austin JE, et al. Economic survivorship stress is associated with poor health-related quality of life among distressed survivors of hematopoietic stem cell transplantation. Psychooncology. 2013;22(4):911–21.

    Article  PubMed  Google Scholar 

  51. Bhatt NS, Palou Torres AK, Myers J, Phelan R, Shaw BE. Work status, missed time at work, work performance, and quality of life in adult survivors of hematopoietic cell transplant in childhood. Presented: Am Soc Hematol Ann Meet. 2021; Orlando, FL.

  52. Kessler RC, Barber C, Beck A, et al. The world health organization health and work performance questionnaire (HPQ). J Occup Environ Med. 2003;45(2):156–74.

    Article  PubMed  Google Scholar 

  53. Cella D, Yount S, Rothrock N, et al. The Patient-Reported Outcomes Measurement Information System (PROMIS): progress of an NIH Roadmap cooperative group during its first two years. Med Care. 2007;45(5 Suppl 1):S3–11. https://doi.org/10.1097/01.mlr.0000258615.42478.55.

    Article  PubMed  PubMed Central  Google Scholar 

  54. Khera N, Hamilton BK, Pidala JA, et al. Employment, insurance, and financial experiences of patients with chronic graft-versus-host disease in North America. Biol Blood Marrow Transplant. 2019;25(3):599–605. https://doi.org/10.1016/j.bbmt.2018.09.040.

    Article  PubMed  Google Scholar 

  55. Albelda R, Wiemers E, Hahn T, Khera N, Salas Coronado DY, Abel GA. Relationship between paid leave, financial burden, and patient-reported outcomes among employed patients who have undergone bone marrow transplantation. Qual Life Res. 2019;28(7):1835–47. https://doi.org/10.1007/s11136-019-02150-8.

    Article  PubMed  PubMed Central  Google Scholar 

  56. Salit RB, Lee SJ, Burns LJ, et al. Return-to-work guidelines and programs for post-hematopoietic cell transplant survivors: an initial survey. Biol Blood Marrow Transplant. 2020;https://doi.org/10.1016/j.bbmt.2020.04.022. A cross-sectional survey of transplant centers highlighting the need for return-to-work guidelines and programs.

  57. Salit RB, Lee SJ, Syrjala KL. Post-hematopoietic cell transplantation return to work support: a survey of 1–5 year survivors. Presented: Transplant Cell Ther Meet ASTCT CIBMTR. 2021;

  58. Marks DI, Gale DJ, Vedhara K, Bird JM. A quality of life study in 20 adult long-term survivors of unrelated donor bone marrow transplantation. Bone Marrow Transplant. 1999;24(2):191–5. https://doi.org/10.1038/sj.bmt.1701867.

    Article  CAS  PubMed  Google Scholar 

  59. Denzen EM, Thao V, Hahn T, et al. Financial impact of allogeneic hematopoietic cell transplantation on patients and families over 2 years: results from a multicenter pilot study. Bone Marrow Transplant. 2016;51(9):1233–40. https://doi.org/10.1038/bmt.2016.103.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Mosher CE, DuHamel KN, Rini C, Corner G, Lam J, Redd WH. Quality of life concerns and depression among hematopoietic stem cell transplant survivors. Support Care Cancer. 2011;19(9):1357–65.

    Article  PubMed  Google Scholar 

  61. Janicsak H, Masszi T, Remenyi P, Ungvari GS, Gazdag G. Quality of life and its socio-demographic and psychological determinants after bone marrow transplantation. Eur J Haematol. 2013;91(2):135–40. https://doi.org/10.1111/ejh.12126.

    Article  PubMed  Google Scholar 

  62. Vose JM, Kennedy BC, Bierman PJ, Kessinger A, Armitage JO. Long-term sequelae of autologous bone marrow or peripheral stem cell transplantation for lymphoid malignancies. Cancer. 1992;69(3):784–9. https://doi.org/10.1002/1097-0142(19920201)69:3%3c784::aid-cncr2820690328%3e3.0.co;2-m.

    Article  CAS  PubMed  Google Scholar 

  63. Majhail NS, Ness KK, Burns LJ, et al. Late effects in survivors of Hodgkin and non-Hodgkin lymphoma treated with autologous hematopoietic cell transplantation: a report from the bone marrow transplant survivor study. Biol Blood Marrow Transplant. 2007;13(10):1153–9. https://doi.org/10.1016/j.bbmt.2007.06.003.

    Article  PubMed  PubMed Central  Google Scholar 

  64. Chao NJ, Tierney DK, Bloom JR, et al. Dynamic assessment of quality of life after autologous bone marrow transplantation. Blood. 1992;80(3):825–30.

    Article  CAS  PubMed  Google Scholar 

  65. Saleh US, Brockopp DY. Quality of life one year following bone marrow transplantation: psychometric evaluation of the quality of life in bone marrow transplant survivors tool. Oncol Nurs Forum. 2001;28(9):1457–64.

    CAS  PubMed  Google Scholar 

  66. Dyer G, Brice L, Gilroy N, et al. Changes to work status and household income of long-term allogeneic blood and marrow transplant survivors in New South Wales, Australia. Bone Marrow Transplant. 2018;53(7):926–931. https://doi.org/10.1038/s41409-018-0098-4

  67. Ishida Y, Honda M, Kamibeppu K, et al. Social outcomes and quality of life of childhood cancer survivors in Japan: a cross-sectional study on marriage, education, employment and health-related QOL (SF-36). Int J Hematol. 2011;93(5):633–44. https://doi.org/10.1007/s12185-011-0843-6.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinical Research Division, Fred Hutchinson Cancer Center, 1100 Fairview Ave N, D5-390, Seattle, WA, 98109, USA

    Neel S. Bhatt

Authors
  1. Neel S. Bhatt
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Neel S. Bhatt.

Ethics declarations

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Conflict of Interest

The author declares no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Health Economics

Rights and permissions

Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bhatt, N.S. Prevalence and Determinants of Return to Work as a Patient-Centered Outcome in Survivors of Hematopoietic Cell Transplantation. Curr Hematol Malig Rep 17, 228–242 (2022). https://doi.org/10.1007/s11899-022-00678-0

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11899-022-00678-0

Keywords

Search

Navigation